BioVentrix's Unattributed - IV Round

BioVentrix raised a round of funding on March 20, 2012. Investors include Taglich Brothers.

BioVentrix (CHF Technologies) is focused on developing advanced clinical solutions that treat heart failure patients. The company's Blue Egg Sizer is used in conjunction with Left Ventricular Reconstr…

Articles about BioVentrix's Unattributed - IV Round: